Representativity of target families in the Protein Data Bank: impact for family-directed structure-based drug discovery (Q31027566)

28 June 2017

1 reference

title

Representativity of target families in the Protein Data Bank: impact for family-directed structure-based drug discovery (English)

1 reference

28 June 2017

0 references

1 reference

Jordi Mestres

1

0 references

publication date

1 December 2005

1 reference

28 June 2017

1 reference

28 June 2017

10

1 reference

28 June 2017

23-24

1 reference

28 June 2017

1629-1637

1 reference

Chemogenomic approaches to drug discovery

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Chemogenomics: bridging a drug discovery gap.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Chemogenomics: an emerging strategy for rapid target and drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Chemogenomic profiling: identifying the functional interactions of small molecules in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Hit and lead generation: beyond high-throughput screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Protein structure similarity clustering and natural product structure as guiding principles in drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

From words to literature in structural proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Guided docking approaches to structure-based design and screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Docking and scoring in virtual screening for drug discovery: methods and applications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Virtual screening of chemical libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Design, docking, and evaluation of multiple libraries against multiple targets

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Virtual screening of combinatorial libraries across a gene family: in search of inhibitors of Giardia lamblia guanine phosphoribosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Nuclear hormone receptor targeted virtual screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

GRID/CPCA: a new computational tool to design selective ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Structural Differences of Matrix Metalloproteinases with Potential Implications for Inhibitor Selectivity Examined by the GRID/CPCA Approach

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

History of the enzyme nomenclature system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

BRENDA, the enzyme database: updates and major new developments

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

PDBsum: summaries and analyses of PDB structures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Coverage of protein sequence space by current structural genomics targets

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Progress of structural genomics initiatives: an analysis of solved target structures.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

MODBASE, a database of annotated comparative protein structure models, and associated resources.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

Utility of homology models in the drug discovery process.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903593-2

7 January 2021

10.1016/S1359-6446(05)03593-2

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

16376823